COMP <GO>
BLLN vs JNJ // DIVIDEND YIELD & FCF PAYOUT SAFETY
BillionToOne Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BLLN 5
— JNJ 9
■ METRIC PARITY
LAST: $113.32 (-1.32%) • MKT CAP: $5.42B
dividend-safety
0.00%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLLN VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLLN | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | 67.90% | +0.40 | BLLN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | 25.50% | -22.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 18.5x | +76.50 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 0.29% | 2.97% | -2.68 | JNJ | /fcf-yield <GO> |
| Operating Margin | 5.30% | 34.70% | -29.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 2.40% | 28.50% | -26.10 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 100.00% | 6.00% | +94.00 | BLLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.24 | 5.59 | +16.65 | BLLN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | BLLN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 7.20% | -0.20 | BLLN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.5 | 60.4 | -0.87 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.08 | -0.06 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 23.0x | +117.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.42B | $662.49B | -$657.07B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLLN REV | JNJ REV | BLLN GROSS % | JNJ GROSS % | BLLN FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $305.1M | $94.19B | 68.3% | 67.9% | $15.7M | $19.70B |
| FY 2024 | $152.6M | $88.82B | 53.0% | 69.1% | -$46.8M | $19.84B |
| FY 2023 | $71.7M | $85.16B | 44.0% | 44.0% | -$56.9M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLLN // BETA 1.02
JNJ // BETA 1.08